Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

AFFT2 cell

A cellular and precise technology, applied in the field of AFFT2 cells and their preparation, can solve the problem of not considering the self-protection technology of T cells, and achieve the effects of unrestricted killing ability, high killing efficiency and strong target specificity

Active Publication Date: 2019-01-04
BEIJING DCTY BIOTECH CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] None of the above schemes consider the self-protection technology of T cells, so that a small number of specific T cells directly face the powerful tumor microenvironment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • AFFT2 cell
  • AFFT2 cell
  • AFFT2 cell

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] This example will take lung cancer patients as an example to provide targeted AFFT2 cells and their preparation methods:

[0052] 1. Whole Exome Sequencing

[0053] 1) Take peripheral blood from lung cancer patients for ctDNA sequencing and HLA typing;

[0054] 2) Use software to analyze the sequencing information: compare the ctDNA sequencing results with the genome of normal cells, and screen out the mutation sites;

[0055] 2. Epitope prediction

[0056] 1) Take the mutated amino acid site as the center, extend 10 amino acids to both sides, and use this 21-amino acid polypeptide as a "potential antigenic epitope";

[0057] 2) Use prediction software to analyze the IC50 of the potential antigenic epitope (recommended software: NetMHCpan 3.0, PickPocket, artificial neural networks (ANN)), if IC50<1000nM, the potential antigenic epitope is considered as "antigenic epitope";

[0058] 3. Synthetic peptides

[0059] Entrust a technical service company to synthesize a mut...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of biotechnology and particularly relates to an AFFT2 cell and a preparation method of the AFFT2 cell. The cell is transformed through the TCR-T technology, the transformed T cell is closed in vitro through an inhibitory signal molecular antibody drug, so that the anti-tumor capability of the T cell is improved effectively, and among the cell transformed throughthe AFFT2 scheme, the proportion of the specific T cell capable of recognizing a tumor antigen is more than 70%.

Description

Technical field: [0001] The invention belongs to the field of biotechnology, and in particular relates to an AFFT2 cell and a preparation method thereof. Background technique: [0002] At present, in terms of tumor-specific immunotherapy, the existing LAK, DC, CIK, and DC-CIK cells and methods have basically been proven to be ineffective, while NK, CAR-NK, TIL, and other cell technologies have yet to mature. CAR - T cells have shortcomings in safety and solid tumor therapy. [0003] In the prior art, DCs are generally modified to present T cells to produce specific killing. Some laboratories are trying to use viruses as vectors to transfect and present T cells to induce specific killing of T cells. We have also used mutant hybrid peptides to directly stimulate PBMCs to induce T cells. There are also laboratories using TCR-T technology to target the presentation of MAGE A3 antigen. [0004] The above treatment methods are immature, especially the in vitro induction of DC ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/90C12N5/10
CPCC07K14/7051C12N5/0638C12N15/907C12N2510/00C12N2800/80C12N2810/10C12N5/064C12N2502/1121C12N2740/16043C12N15/86C12N2740/15043C12N2810/80
Inventor 焦顺昌张嵘周子珊解佳森陈小彬彭刚陈红利
Owner BEIJING DCTY BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com